Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J9PD
|
|||
| Former ID |
DIB016554
|
|||
| Drug Name |
STP-206
|
|||
| Synonyms |
Live-bacteria-based biologic (necrotizing enterocolitis), Sigma-Tau Pharmaceuticals/Danisco
Click to Show/Hide
|
|||
| Indication | Necrotizing enterocolitis of newborn [ICD-11: KB88; ICD-10: P77] | Phase 2 | [1] | |
| Enterocolitis [ICD-11: 1A40.Z] | Phase 1/2 | [2] | ||
| Company |
Sigma-Tau Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT01954017) STP206 for the Prevention of NEC. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.